{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:08Z","timestamp":1787070848194,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine carcinoma of the skin. In this study, we aimed to evaluate the clinicopathologic characteristics, treatment outcomes, and survival of MCC cases in Turkey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The patients diagnosed with MCC between 1999 and 2018 at twenty different centers in Turkey were included in the study. Patient and tumor characteristics and adjuvant and metastatis treatment outcomes were analyzed retrospectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The median age of totally 89 patients was 70 (26\u201393). The most common primary location was lower limbs (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 29, 32.5%). Immunohistochemically, CK20 positivity was present in 59 patients (66.3%). Only two patients had secondary malignancy. The majority of the patients (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 76, 85.4%) were diagnosed at the localized stage. Surgery was performed for all patients in the early stage, and adjuvant radiotherapy or\/and chemotherapy was applied to 52.6% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 40) of nonmetastatic patients. The median follow-up was 29 months. Recurrence developed in 21 (27.6%) of the 76 patients who presented with local or regional disease. Two-year disease-free survival (DFS) was 68.1% and 5-year DFS was 62.0% for localized stage. The 5-year DFS was similar for patients receiving adjuvant treatment (chemotherapy, radiotherapy, or sequential chemoradiotherapy) and without adjuvant therapy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). Two-year overall survival in patients who presented with localized disease was 71.3% and 18.5% in metastatic patients (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). In the metastatic stage, platinum\/etoposide combination was the most preferred combination regimen. Median progression-free survival (PFS) in first-line chemotherapy was 7 months (95% confidence interval: 3.5\u201310.5 months; standart error: 1.78).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Although MCC is rare in Turkey, the incidence is increasing. Gender, CK20 status, tumor size, lymph node involvement, and adjuvant treatment were not associated with recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_950_19","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T02:33:28Z","timestamp":1604370808000},"page":"1525-1529","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Merkel cell carcinoma in Turkey"],"prefix":"10.4103","volume":"17","author":[{"given":"Fatih","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"K\u00fc\u00e7\u00fckarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"B\u00fcy\u00fcksimsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teoman","family":"Sakalar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turkan Ozturk","family":"Topcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferit","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnihal","family":"Tufan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovgu","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"Turna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalan Akgul","family":"Babacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Basoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bediz","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birol","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fclay","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atike Gokcen","family":"Demiray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Gumusay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuriye","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuksel","family":"Urun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Baykara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedim","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukremin","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Bilici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Kavgaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rfan","family":"\u00c7i\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadettin","family":"Kilickap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra","family":"Paydas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20241021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.hoc.2018.08.002","article-title":"Merkel Cell Carcinoma Review","volume":"33","author":"Xue","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"R2-36-20241021","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","article-title":"The biology and treatment of Merkel cell carcinoma: Current understanding and research priorities","volume":"15","author":"Harms","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R3-36-20241021","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","article-title":"Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics","volume":"78","author":"Paulson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R4-36-20241021","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0560.2009.01370.x","article-title":"Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: A population based study","volume":"37","author":"Albores-Saavedra","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R5-36-20241021","doi-asserted-by":"crossref","first-page":"dju382","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R6-36-20241021","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/annonc\/mdq308","article-title":"Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: An old bond with possible new viral ties","volume":"22","author":"Tadmor","year":"2011","journal-title":"Ann Oncol"},{"key":"R7-36-20241021","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(02)07668-7","article-title":"Merkel cell carcinoma and HIV infection","volume":"359","author":"Engels","year":"2002","journal-title":"Lancet"},{"key":"R8-36-20241021","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/1055-9965.EPI-05-0895","article-title":"Merkel cell carcinoma and multiple primary cancers","volume":"15","author":"Howard","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R9-36-20241021","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jdv.13828","article-title":"Merkel cell carcinoma: Rising incidence in the east of England","volume":"30","author":"Goon","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-36-20241021","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/cancers10100350","article-title":"Prognostic factors in merkel cell carcinoma: A retrospective single-center study in 90 patients","volume":"10","author":"Rastrelli","year":"2018","journal-title":"Cancers (Basel"},{"key":"R11-36-20241021","doi-asserted-by":"crossref","first-page":"e0129476","DOI":"10.1371\/journal.pone.0129476","article-title":"Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience","volume":"10","author":"Liang","year":"2015","journal-title":"PLoS One"},{"key":"R12-36-20241021","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejca.2010.11.002","article-title":"Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007","volume":"47","author":"Reichgelt","year":"2011","journal-title":"Eur J Cancer"},{"key":"R13-36-20241021","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th Edition AJCC Staging System","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R14-36-20241021","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","article-title":"Merkel cell carcinoma: Prognosis and treatment of patients from a single institution","volume":"23","author":"Allen","year":"2005","journal-title":"J Clin Oncol"},{"key":"R15-36-20241021","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamadermatol.2014.124","article-title":"Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R16-36-20241021","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"key":"R17-36-20241021","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"key":"R18-36-20241021","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/14737140.2018.1445528","article-title":"Avelumab: A new standard for treating metastatic Merkel cell carcinoma","volume":"18","author":"Baker","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R19-36-20241021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jama.2018.7042","article-title":"Why merkel cell cancer is garnering more attention","volume":"320","author":"Voelker","year":"2018","journal-title":"JAMA"},{"key":"R20-36-20241021","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-4632.2011.05251.x","article-title":"The clinical profile of Merkel cell carcinoma in mainland China","volume":"51","author":"Song","year":"2012","journal-title":"Int J Dermatol"},{"key":"R21-36-20241021","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.31860","article-title":"Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France","volume":"144","author":"Kieny","year":"2019","journal-title":"Int J Cancer"},{"key":"R22-36-20241021","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1245\/s10434-012-2779-3","article-title":"Merkel cell carcinoma: 30-year experience from a single institution","volume":"20","author":"Santamaria-Barria","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R23-36-20241021","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/jdv.13698","article-title":"Merkel cell carcinoma incidence is increasing in Sweden","volume":"30","author":"Zaar","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-36-20241021","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jnci\/djq120","article-title":"Merkel cell carcinoma: Incidence, mortality, and risk of other cancers","volume":"102","author":"Kaae","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R25-36-20241021","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejca.2011.06.001","article-title":"Merkel cell carcinoma-a population-based epidemiological study in Finland with a clinical series of 181 cases","volume":"48","author":"Kukko","year":"2012","journal-title":"Eur J Cancer"},{"key":"R26-36-20241021","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/jdv.14798","article-title":"Merkel cell carcinoma in France: A registries-based, comprehensive epidemiological survey","volume":"32","author":"Fondain","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R27-36-20241021","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10434-001-0204-4","article-title":"Multimodality treatment of Merkel cell carcinoma: Case series and literature review of 1024 cases","volume":"8","author":"Medina-Franco","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"R28-36-20241021","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archderm.142.6.693","article-title":"Adjuvant local irradiation for Merkel cell carcinoma","volume":"142","author":"Lewis","year":"2006","journal-title":"Arch Dermatol"},{"key":"R29-36-20241021","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/cncr.26626","article-title":"Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma","volume":"118","author":"Fields","year":"2012","journal-title":"Cancer"},{"key":"R30-36-20241021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13555-019-0288-z","article-title":"Merkel cell carcinoma: Therapeutic update and emerging therapies","volume":"9","author":"Villani","year":"2019","journal-title":"Dermatol Ther (Heidelb"},{"key":"R31-36-20241021","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1067\/mjd.2002.125083","article-title":"Local control of primary Merkel cell carcinoma: Review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation","volume":"47","author":"Boyer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R32-36-20241021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jnci\/djx052","article-title":"Adjuvant radiation therapy and chemotherapy in merkel cell carcinoma: Survival analyses of 6908 cases from the national cancer data base","volume":"109","author":"Vargo","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R33-36-20241021","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2005.04.042","article-title":"Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?","volume":"64","author":"Poulsen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-36-20241021","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2013.11.031","article-title":"Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma","volume":"70","author":"Iyer","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R35-36-20241021","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","article-title":"Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system","volume":"63","author":"Lemos","year":"2010","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_950_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:35Z","timestamp":1787067455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_950_19"}},"subtitle":["A multicentric study"],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_950_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}